These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15006288)

  • 41. Stigma, discrimination and the health of illicit drug users.
    Ahern J; Stuber J; Galea S
    Drug Alcohol Depend; 2007 May; 88(2-3):188-96. PubMed ID: 17118578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Research design strategies to evaluate the impact of formulations on abuse liability.
    McColl S; Sellers EM
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S52-62. PubMed ID: 16554125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accuracy of current clinical diagnosis in recreational drug-related attendance to the emergency department.
    West E; Cameron P; O'Reilly G; Drummer OH; Bystrzycki A
    Emerg Med Australas; 2008 Aug; 20(4):333-8. PubMed ID: 18782207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testing for drugs of abuse.
    Colyar MR
    Adv Nurse Pract; 2003 Sep; 11(9):30-1. PubMed ID: 14521106
    [No Abstract]   [Full Text] [Related]  

  • 46. Remission from drug dependence symptoms and drug use cessation among women drug users in puerto rico.
    Warner LA; Alegría M; Canino G
    Arch Gen Psychiatry; 2004 Oct; 61(10):1034-41. PubMed ID: 15466677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
    Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
    J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Opinionating difficulties in cases concerning the use of psychoactive agents by traffic participants].
    Olszowy Z; Albert M; Celiński R; Kulikowska J; Rojek S
    Arch Med Sadowej Kryminol; 2007; 57(2):210-4. PubMed ID: 17691178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues.
    Wang J; Falck RS; Li L; Rahman A; Carlson RG
    Addict Behav; 2007 May; 32(5):924-37. PubMed ID: 16901654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Results and prospects of development of neuropharmacology in the department of pharmacology of the Acad. S. V. Anichkov Research Institute of Experimental Medicine, USSR Academy of Medical Sciences].
    Borodkin IuS; Zavodskaia IS; Losev NA; Moreva EV; Sapronov NS
    Vestn Akad Med Nauk SSSR; 1990; (11):16-23. PubMed ID: 2284839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for drug use disorders in the emergency department: performance of the rapid drug problems screen (RDPS).
    Cherpitel CJ; Borges G
    Drug Alcohol Depend; 2004 May; 74(2):171-5. PubMed ID: 15099660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drugs in oral fluid Part II. Investigation of drugs in drivers.
    Wylie FM; Torrance H; Seymour A; Buttress S; Oliver JS
    Forensic Sci Int; 2005 Jun; 150(2-3):199-204. PubMed ID: 15944060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New drugs of abuse in North America.
    Haroz R; Greenberg MI
    Clin Lab Med; 2006 Mar; 26(1):147-64, ix. PubMed ID: 16567229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
    Newcombe DA; Humeniuk RE; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache.
    Schuckman H; Hazelett S; Powell C; Steer S
    Subst Use Misuse; 2008; 43(5):589-95. PubMed ID: 18393078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
    Zacny JP; Gutierrez S
    Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The economics of drug abuse: a quantitative assessment of drug demand.
    Hursh SR; Galuska CM; Winger G; Woods JH
    Mol Interv; 2005 Feb; 5(1):20-8. PubMed ID: 15731502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
    Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.